Roche

FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch
FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch
Endpoints
Merck
FDA
complete response letter
Keytruda
Eisaid
Lenvima
hepatocellular carcinoma
Roche
Flag link:
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug
Xconomy
Roche
HER2+ breast cancer
FDA
Phesgo
Flag link:
Roche, BioNTech post 'low' response rate in cancer vaccine trial
Roche, BioNTech post 'low' response rate in cancer vaccine trial
Fierce Biotech
Roche
BioNTech
vaccines
personalized medicine
clinical trials
RO7198457
Flag link:
Roche phase 3 hits goal in subgroup of prostate cancer patients
Roche phase 3 hits goal in subgroup of prostate cancer patients
Fierce Biotech
Roche
clinical trials
Ipatasertib
prostate cancer
Flag link:
The ipatasertib curate’s egg
The ipatasertib curate’s egg
EP Vantage
Roche
akt protein inhibitor
prostate cancer
Ipatasertib
Flag link:
Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study
Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study
BioSpace
Roche
Genentech
Tecentriq
triple negative breast cancer
clinical trials
Celgene
Abraxane
Flag link:
Roche's Actemra falls short in Italian study in early-stage COVID-19 pneumonia
Roche's Actemra falls short in Italian study in early-stage COVID-19 pneumonia
Fierce Pharma
Roche
Actgemra
COVID-19 pneumonia
COVID-19
clinical trials
Flag link:
NICE backs funding for Roche’s lung cancer drug after price cut
NICE backs funding for Roche’s lung cancer drug after price cut
Pharmaforum
NICE
Roche
Rozlytrek
non-small cell lung cancer
Flag link:
EHA: AbbVie, Roche cement Venclexta's place in AML with survival win
EHA: AbbVie, Roche cement Venclexta's place in AML with survival win
Fierce Pharma
AbbVie
Roche
Venclexta
AML
EHA
Flag link:
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
Beckers Hospital Review
OptumRx
Roche
PTC Therapeutics
risdiplam
SMA
NS Pharma
viltolarsen
Duchenne Muscular Dystrophy
Immunomedics
Trodelvy
triple negative breast cancer
Flag link:
Roche pens $2B biobucks pact with Innovent Biologics for bispecific and cell therapies
Roche pens $2B biobucks pact with Innovent Biologics for bispecific and cell therapies
Fierce Biotech
Roche
Innovent Biologics
China
bispecific antibodies
cell therapy
Flag link:
Drug manufacturing giant Lonza taps Roche/pharma ‘reinvention’ vet as its new CEO
Drug manufacturing giant Lonza taps Roche/pharma ‘reinvention’ vet as its new CEO
Endpoints
Lonza
Pharma CEOs
Roche
Pierre-Alain Ruffieux
drug manufacturing
Flag link:
FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’
FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’
Pharmaforum
Roche
diagnostics
COVID-19
FDA
cytokine storm
Flag link:
Roche nabs frontline OK for Avastin/Tecentriq in common liver cancer, besting an old Bayer drug
Roche nabs frontline OK for Avastin/Tecentriq in common liver cancer, besting an old Bayer drug
Endpoints
Roche
Avastin
Tecentriq
metastatic hepatocellular carcinoma
liver cancer
FDA
Flag link:
Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir
Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir
BioSpace
Roche
Gilead Sciences
clinical trials
Actemra
RoActemra
remdesivir
COVID-19
pneumonia
COVID-19 pneumonia
Flag link:
Roche signs up with Oncimmune to explore immunotherapy responses
Roche signs up with Oncimmune to explore immunotherapy responses
Pharmaforum
Roche
Oncimmune
autoantibodies
immunotherapy
Flag link:
Roche beefs up diagnostic arm with another bet on faster, cheaper DNA sequencing
Roche beefs up diagnostic arm with another bet on faster, cheaper DNA sequencing
Endpoints
Roche
Stratos Genomics
DNA
M&A
DNA sequencing
Flag link:
Big pharma heads towards important readouts
Big pharma heads towards important readouts
EP Vantage
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
Flag link:
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
Fierce Pharma
cancer
JNJ
AbbVie
Roche
pharma advertising
oncology
Flag link:
3 Roche Companies Hope to Make Clinical Trials More Efficient
3 Roche Companies Hope to Make Clinical Trials More Efficient
Medical Devices and Diagnostics Industry
Flatiron Health
Foundation Medicine
Genentech
Roche
genomics
clinical trials
lung cancer
Flag link:

Pages